227 related articles for article (PubMed ID: 24994818)
1. Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice.
Honjo K; Kubagawa Y; Suzuki Y; Takagi M; Ohno H; Bucy RP; Izui S; Kubagawa H
Int Immunol; 2014 Dec; 26(12):659-72. PubMed ID: 24994818
[TBL] [Abstract][Full Text] [Related]
2. FcμR in human B cell subsets in primary selective IgM deficiency, and regulation of FcμR and production of natural IgM antibodies by IGIV.
Gupta S; Agrawal S; Gollapudi S; Kubagawa H
Hum Immunol; 2016 Dec; 77(12):1194-1201. PubMed ID: 27751883
[TBL] [Abstract][Full Text] [Related]
3. Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR).
Honjo K; Kubagawa Y; Jones DM; Dizon B; Zhu Z; Ohno H; Izui S; Kearney JF; Kubagawa H
Proc Natl Acad Sci U S A; 2012 Sep; 109(39):15882-7. PubMed ID: 22984178
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Mott cell formation linked with IgM Fc receptor (FcμR) deficiency.
Mahmoudi Aliabadi P; Al-Qaisi K; Jani PK; Honjo K; Klemm U; Lee KH; Baumgarth N; Radbruch A; Melchers F; Kubagawa H
Eur J Immunol; 2023 Jul; 53(7):e2250315. PubMed ID: 37098762
[TBL] [Abstract][Full Text] [Related]
5. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus.
Satoh M; Weintraub JP; Yoshida H; Shaheen VM; Richards HB; Shaw M; Reeves WH
J Immunol; 2000 Jul; 165(2):1036-43. PubMed ID: 10878381
[TBL] [Abstract][Full Text] [Related]
6. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI.
Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH
Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365
[TBL] [Abstract][Full Text] [Related]
7. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses.
Ouchida R; Mori H; Hase K; Takatsu H; Kurosaki T; Tokuhisa T; Ohno H; Wang JY
Proc Natl Acad Sci U S A; 2012 Oct; 109(40):E2699-706. PubMed ID: 22988094
[TBL] [Abstract][Full Text] [Related]
8. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells.
Fields ML; Sokol CL; Eaton-Bassiri A; Seo S; Madaio MP; Erikson J
J Immunol; 2001 Aug; 167(4):2370-8. PubMed ID: 11490027
[TBL] [Abstract][Full Text] [Related]
9. Functional Roles of the IgM Fc Receptor in the Immune System.
Kubagawa H; Honjo K; Ohkura N; Sakaguchi S; Radbruch A; Melchers F; Jani PK
Front Immunol; 2019; 10():945. PubMed ID: 31130948
[TBL] [Abstract][Full Text] [Related]
10. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.
Jiang C; Foley J; Clayton N; Kissling G; Jokinen M; Herbert R; Diaz M
J Immunol; 2007 Jun; 178(11):7422-31. PubMed ID: 17513793
[TBL] [Abstract][Full Text] [Related]
12. Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses.
Choi SC; Wang H; Tian L; Murakami Y; Shin DM; Borrego F; Morse HC; Coligan JE
J Immunol; 2013 Feb; 190(3):987-96. PubMed ID: 23267023
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitor Cdkn2c deficiency promotes B1a cell expansion and autoimmunity in a mouse model of lupus.
Potula HH; Xu Z; Zeumer L; Sang A; Croker BP; Morel L
J Immunol; 2012 Sep; 189(6):2931-40. PubMed ID: 22896639
[TBL] [Abstract][Full Text] [Related]
14. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
[TBL] [Abstract][Full Text] [Related]
15. Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response.
Santulli-Marotto S; Qian Y; Ferguson S; Clarke SH
J Immunol; 2001 Apr; 166(8):5292-9. PubMed ID: 11290816
[TBL] [Abstract][Full Text] [Related]
16. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
Yajima K; Nakamura A; Sugahara A; Takai T
Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
[TBL] [Abstract][Full Text] [Related]
17. Deletion of receptor for advanced glycation end products exacerbates lymphoproliferative syndrome and lupus nephritis in B6-MRL Fas lpr/j mice.
Goury A; Meghraoui-Kheddar A; Belmokhtar K; Vuiblet V; Ortillon J; Jaisson S; Devy J; Le Naour R; Tabary T; Cohen JH; Schmidt AM; Rieu P; Touré F
J Immunol; 2015 Apr; 194(8):3612-22. PubMed ID: 25762779
[TBL] [Abstract][Full Text] [Related]
18. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
[TBL] [Abstract][Full Text] [Related]
19. Autoreactive MZ and B-1 B-cell activation by Faslpr is coincident with an increased frequency of apoptotic lymphocytes and a defect in macrophage clearance.
Qian Y; Conway KL; Lu X; Seitz HM; Matsushima GK; Clarke SH
Blood; 2006 Aug; 108(3):974-82. PubMed ID: 16861350
[TBL] [Abstract][Full Text] [Related]
20. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
